MILLIGAN MICHAEL LEE (See Remarks) sold 6.4% of their position (1.44K shares) of NEUMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001610717-26-000051
Officer· See Remarks
Since Feb 2026
-1.44K
Net shares
Net seller
$5.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.44K
Price / share
$3.56
Trade value
$5.12K
% of position
6.4%
2/17/2026
22.47K→21.03K
Total
Net shares
−1.44K
Net value
-$5.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | S · Sale | −1.44K | $3.56 | $5.12K | 6.4% | 22.47K | 21.03K |
| Total | −1.44K | -$5.12K | ||||||
Derivative Transactions0
No derivative transactions reported